20 November 2020
Company Announcements Office Australian Securities Exchange
I-MED to upgrade their 200+ trophon® EPR fleet to trophon2
Nanosonics (ASX: NAN), a leader in infection prevention solutions, announces that I-MED Radiology Network has signed an agreement to upgrade their entire fleet of over 200 trophon EPRs to the new trophon2.
I-MED is Australia’s largest and one of the world’s most respected imaging specialist groups. The I- MED Network was one of the first adopters of trophon EPRs and today are the largest user of the trophon technology in Australia.
In addition to upgrading their entire trophon EPR fleet, I-MED is further expanding its trophon installed base to ensure all clinics in their growing network have a group wide standardised practice for automated high level disinfection of ultrasound transducers as well as state of the art disinfection traceability.
“We are proud to continue our partnership with I-MED as they upgrade their entire fleet of over 200 trophon EPRs to the new trophon2. The trophon2 brings enhanced clinical workflow as well as full traceability for ultrasound probe decontamination to their entire network.” said Michael Kavanagh, Nanosonics CEO & President.
“Nanosonics has over 24,000 trophon units installed globally, the majority of which are the first generation trophon EPR model. In 2018 Nanosonics introduced the trophon 2 model which delivers a range of important benefits to customers across usability, clinical efficiency and traceability. These customer benefits present a significant opportunity for upgrades from the trophon EPR to trophon 2 over time,” said Michael Kavanagh.
Michael Kavanagh CEO / President
This announcement has been authorised by the Board of Directors of Nanosonics.
For more information, please contact:
Michael Kavanagh, CEO / President or McGregor Grant, CFO, on (02) 8063 1600.
